首页 > 最新文献

British journal of rheumatology最新文献

英文 中文
A study of the frequency of pericardial and pleural effusions in scleroderma. 硬皮病患者心包积液和胸腔积液频率的研究。
Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1320
A E Thompson, J E Pope

Objective: To determine the frequency of pericardial and pleural effusions in scleroderma.

Methods: Using a case-control format, patients with scleroderma and no known cardiac disease were recruited. Echocardiograms and chest radiographs were performed. Age- and gender-matched controls had echocardiograms performed which were read by a cardiologist, blinded to the diagnosis. The medical records of 60 other scleroderma patients were also reviewed.

Results: Thirty-seven scleroderma subjects were recruited, of whom 18 had diffuse disease. Only eight subjects with diffuse disease and five with limited scleroderma had normal echocardiograms compared to 20 of 37 controls (P < 0.1). Two had pericardial effusions, both with diffuse scleroderma, and none of the controls had effusions present. Pulmonary hypertension occurred in three with diffuse disease and no controls. A chart review of a further 60 patients with scleroderma was performed. Pleural effusions were identified in 7% (4/58) of the cohort of scleroderma patients and were more frequent in diffuse disease (10%). A total of 17% (4/23) of diffuse and 4% (1/23) of limited scleroderma patients had evidence of pericardial effusions.

Conclusions: Pericardial effusions do occur in scleroderma without evidence of clinical cardiac dysfunction and are more common in diffuse scleroderma. Pleural effusions in scleroderma occur less frequently, in 70%.

目的:探讨硬皮病患者心包积液和胸腔积液的发生频率。方法:采用病例-对照形式,招募患有硬皮病且无已知心脏病的患者。进行超声心动图和胸片检查。年龄和性别匹配的对照组进行超声心动图,由心脏病专家阅读,对诊断不知情。还审查了其他60名硬皮病患者的医疗记录。结果:纳入37例硬皮病患者,其中弥漫性疾病18例。只有8名弥漫性疾病患者和5名局限性硬皮病患者超声心动图正常,而对照组的37名患者中有20名超声心动图正常(P < 0.1)。2例有心包积液,均伴弥漫性硬皮病,对照组无积液。3例弥漫性疾病发生肺动脉高压,无对照。对另外60例硬皮病患者进行了图表回顾。7%(4/58)的硬皮病患者发现胸腔积液,弥漫性疾病更常见(10%)。17%(4/23)的弥漫性硬皮病患者和4%(1/23)的局限性硬皮病患者有心包积液的证据。结论:心包积液确实发生在无临床心功能障碍证据的硬皮病中,在弥漫性硬皮病中更为常见。硬皮病患者胸腔积液发生率较低,约为70%。
{"title":"A study of the frequency of pericardial and pleural effusions in scleroderma.","authors":"A E Thompson,&nbsp;J E Pope","doi":"10.1093/rheumatology/37.12.1320","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1320","url":null,"abstract":"<p><strong>Objective: </strong>To determine the frequency of pericardial and pleural effusions in scleroderma.</p><p><strong>Methods: </strong>Using a case-control format, patients with scleroderma and no known cardiac disease were recruited. Echocardiograms and chest radiographs were performed. Age- and gender-matched controls had echocardiograms performed which were read by a cardiologist, blinded to the diagnosis. The medical records of 60 other scleroderma patients were also reviewed.</p><p><strong>Results: </strong>Thirty-seven scleroderma subjects were recruited, of whom 18 had diffuse disease. Only eight subjects with diffuse disease and five with limited scleroderma had normal echocardiograms compared to 20 of 37 controls (P < 0.1). Two had pericardial effusions, both with diffuse scleroderma, and none of the controls had effusions present. Pulmonary hypertension occurred in three with diffuse disease and no controls. A chart review of a further 60 patients with scleroderma was performed. Pleural effusions were identified in 7% (4/58) of the cohort of scleroderma patients and were more frequent in diffuse disease (10%). A total of 17% (4/23) of diffuse and 4% (1/23) of limited scleroderma patients had evidence of pericardial effusions.</p><p><strong>Conclusions: </strong>Pericardial effusions do occur in scleroderma without evidence of clinical cardiac dysfunction and are more common in diffuse scleroderma. Pleural effusions in scleroderma occur less frequently, in 70%.</p>","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1320-3"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1320","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 72
Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. 6个月长期体能训练对多发性肌炎/皮肌炎患者的益处
Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1338
G F Wiesinger, M Quittan, M Graninger, A Seeber, G Ebenbichler, B Sturm, K Kerschan, J Smolen, W Graninger

Objective: The benefit of long-term physical training in patients with chronic polymyositis or dermatomyositis (PM/DM) was studied prospectively.

Methods: Eight patients with chronic PM/DM participated in a training programme for 6 months. A group of five PM/DM patients without any physical training was observed for control purposes.

Results: While there was no significant change in serum creatine phosphokinase (CPK) levels, the 'activities of daily living (ADL)' score improved significantly (P < 0.03), peak isometric torque (PIT) generated by muscle groups in the lower extremities rose significantly (P < 0.03) and there was a statistically highly significant increase in peak oxygen uptake (VO2max) relative to body weight (P < 0.02) due to the long-term training. The patients improved their aerobic capacity by 28%, which is clinically significant. In the untrained patients, no improvement in these target parameters was observed.

Conclusion: In clinically stable DM/PM patients, long-term physical training can safely be performed and is recommended as part of a comprehensive rehabilitation management, particularly in view of the cardiopulmonary risk in these patients.

目的:前瞻性研究慢性多发性肌炎或皮肌炎(PM/DM)患者长期体育锻炼的益处。方法:对8例慢性PM/DM患者进行为期6个月的培训。一组5名未进行任何体育锻炼的PM/DM患者作为对照。结果:在血清肌酸磷酸激酶(CPK)水平无明显变化的同时,“日常生活活动(ADL)”评分显著提高(P < 0.03),下肢肌群产生的峰值等距扭矩(PIT)显著升高(P < 0.03),相对于体重的峰值摄氧量(VO2max)因长期训练而显著升高(P < 0.02)。患者的有氧能力提高了28%,具有临床意义。在未经训练的患者中,没有观察到这些目标参数的改善。结论:对于临床稳定的DM/PM患者,可以安全地进行长期体育锻炼,并建议将其作为综合康复管理的一部分,特别是考虑到这些患者的心肺风险。
{"title":"Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients.","authors":"G F Wiesinger,&nbsp;M Quittan,&nbsp;M Graninger,&nbsp;A Seeber,&nbsp;G Ebenbichler,&nbsp;B Sturm,&nbsp;K Kerschan,&nbsp;J Smolen,&nbsp;W Graninger","doi":"10.1093/rheumatology/37.12.1338","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1338","url":null,"abstract":"<p><strong>Objective: </strong>The benefit of long-term physical training in patients with chronic polymyositis or dermatomyositis (PM/DM) was studied prospectively.</p><p><strong>Methods: </strong>Eight patients with chronic PM/DM participated in a training programme for 6 months. A group of five PM/DM patients without any physical training was observed for control purposes.</p><p><strong>Results: </strong>While there was no significant change in serum creatine phosphokinase (CPK) levels, the 'activities of daily living (ADL)' score improved significantly (P < 0.03), peak isometric torque (PIT) generated by muscle groups in the lower extremities rose significantly (P < 0.03) and there was a statistically highly significant increase in peak oxygen uptake (VO2max) relative to body weight (P < 0.02) due to the long-term training. The patients improved their aerobic capacity by 28%, which is clinically significant. In the untrained patients, no improvement in these target parameters was observed.</p><p><strong>Conclusion: </strong>In clinically stable DM/PM patients, long-term physical training can safely be performed and is recommended as part of a comprehensive rehabilitation management, particularly in view of the cardiopulmonary risk in these patients.</p>","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1338-42"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1338","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 112
Post-streptococcal reactive myalgia: a novel syndrome secondary to infection with group A or G streptococci. 链球菌感染后反应性肌痛:一种继发于a组或G组链球菌感染的新型综合征。
Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1343
T L Jansen, M Janssen, J D Macfarlane, A J de Jong
{"title":"Post-streptococcal reactive myalgia: a novel syndrome secondary to infection with group A or G streptococci.","authors":"T L Jansen,&nbsp;M Janssen,&nbsp;J D Macfarlane,&nbsp;A J de Jong","doi":"10.1093/rheumatology/37.12.1343","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1343","url":null,"abstract":"","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1343-8"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1343","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Haemophagocytic syndrome in a patient with dermatomyositis. 皮肌炎患者的噬血细胞综合征。
Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1357
S Yasuda, A Tsutsumi, T Nakabayashi, T Horita, K Ichikawa, M Ieko, T Koike
{"title":"Haemophagocytic syndrome in a patient with dermatomyositis.","authors":"S Yasuda,&nbsp;A Tsutsumi,&nbsp;T Nakabayashi,&nbsp;T Horita,&nbsp;K Ichikawa,&nbsp;M Ieko,&nbsp;T Koike","doi":"10.1093/rheumatology/37.12.1357","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1357","url":null,"abstract":"","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1357-8"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1357","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
Sensorineural hearing loss, iritis and ankylosing spondylitis. 感音神经性听力损失,虹膜炎和强直性脊柱炎。
Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1363
K Raza, D Karokis, F Wilson, J P Delamere
{"title":"Sensorineural hearing loss, iritis and ankylosing spondylitis.","authors":"K Raza,&nbsp;D Karokis,&nbsp;F Wilson,&nbsp;J P Delamere","doi":"10.1093/rheumatology/37.12.1363","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1363","url":null,"abstract":"","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1363"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1363","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE. 针对糖基化IgG的类风湿性关节炎新抗体:IgM抗IgG- age。
Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1307
S Ligier, P R Fortin, M M Newkirk

Hyperglycaemia and/or oxidative stress can cause IgG to be modified by advanced glycation end products (AGE). Three patients with aggressive rheumatoid arthritis (RA) and vasculitis are described who have high titres of IgM antibodies against AGE-modified IgG (IgM anti-IgG-AGE). Diabetics and randomly selected patients with rheumatic diseases, including 50 additional RA patients, were tested for IgM and IgA anti-IgG-AGE by ELISA. AGE-modified proteins were detected using the nitroblue tetrazolium (NBT) colorimetric method. The presence of Nepsilon (carboxymethyl) lysine, an AGE modification, was detected on IgG-AGE by immunoblotting. A total of 20/41 (49%) rheumatoid factor (RF)-positive RA patients tested had IgM anti-IgG-AGE antibodies, 4/12 (33%) RF-positive systemic lupus erythematosus (SLE) patients, 3/5 RF-positive patients with primary Sjogren's syndrome (SS), and 3/5 RF-positive diabetics. All patients with RF-negative RA, SLE, SS, osteoarthritis (24), spondyloarthritis (15), adult-onset Still's disease (8), diabetes (25) and healthy controls (20) were anti-IgG-AGE negative. RF and IgM anti-IgG-AGE appeared to be a linked response. The IgM anti-IgG-AGE, along with IgG-AGE, may contribute to the pathogenesis of RA.

高血糖和/或氧化应激可导致IgG被晚期糖基化终产物(AGE)修饰。本文报道了3例侵袭性类风湿关节炎(RA)和血管炎患者,他们对age修饰的IgG (IgM抗IgG- age)具有高滴度的IgM抗体。糖尿病患者和随机选择的风湿病患者,包括50名RA患者,通过ELISA检测IgM和IgA抗igg - age。采用硝基蓝四氮唑(NBT)比色法检测age修饰蛋白。免疫印迹法在IgG-AGE上检测AGE修饰物Nepsilon(羧甲基)赖氨酸的存在。共有20/41(49%)类风湿因子(RF)阳性的RA患者检测出IgM抗igg - age抗体,4/12 (33%)RF阳性的系统性红斑狼疮(SLE)患者,3/5 RF阳性的原发性干燥综合征(SS)患者和3/5 RF阳性的糖尿病患者。rf阴性的RA、SLE、SS、骨关节炎(24例)、脊椎关节炎(15例)、成人发病Still’s病(8例)、糖尿病(25例)和健康对照(20例)抗igg - age均为阴性。RF和IgM抗igg - age似乎是一个相关的反应。IgM抗IgG-AGE与IgG-AGE可能共同参与RA的发病机制。
{"title":"A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE.","authors":"S Ligier,&nbsp;P R Fortin,&nbsp;M M Newkirk","doi":"10.1093/rheumatology/37.12.1307","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1307","url":null,"abstract":"<p><p>Hyperglycaemia and/or oxidative stress can cause IgG to be modified by advanced glycation end products (AGE). Three patients with aggressive rheumatoid arthritis (RA) and vasculitis are described who have high titres of IgM antibodies against AGE-modified IgG (IgM anti-IgG-AGE). Diabetics and randomly selected patients with rheumatic diseases, including 50 additional RA patients, were tested for IgM and IgA anti-IgG-AGE by ELISA. AGE-modified proteins were detected using the nitroblue tetrazolium (NBT) colorimetric method. The presence of Nepsilon (carboxymethyl) lysine, an AGE modification, was detected on IgG-AGE by immunoblotting. A total of 20/41 (49%) rheumatoid factor (RF)-positive RA patients tested had IgM anti-IgG-AGE antibodies, 4/12 (33%) RF-positive systemic lupus erythematosus (SLE) patients, 3/5 RF-positive patients with primary Sjogren's syndrome (SS), and 3/5 RF-positive diabetics. All patients with RF-negative RA, SLE, SS, osteoarthritis (24), spondyloarthritis (15), adult-onset Still's disease (8), diabetes (25) and healthy controls (20) were anti-IgG-AGE negative. RF and IgM anti-IgG-AGE appeared to be a linked response. The IgM anti-IgG-AGE, along with IgG-AGE, may contribute to the pathogenesis of RA.</p>","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1307-14"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1307","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 65
Sternum tumour revealing a chronic myeloid leukaemia. 胸骨肿瘤显示慢性髓性白血病。
Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1353
E Blot, J Miquel, F Heron, H Tilly, H Levesque, H Courtois
{"title":"Sternum tumour revealing a chronic myeloid leukaemia.","authors":"E Blot,&nbsp;J Miquel,&nbsp;F Heron,&nbsp;H Tilly,&nbsp;H Levesque,&nbsp;H Courtois","doi":"10.1093/rheumatology/37.12.1353","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1353","url":null,"abstract":"","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1353-4"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1353","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
IgA class serum antibodies against three different Klebsiella serotypes in ankylosing spondylitis. 强直性脊柱炎中抗三种不同克雷伯氏菌血清型的IgA类血清抗体。
Pub Date : 1998-12-01
O Mäki-Ikola, M Nissilä, K Lehtinen, K Granfors

Objective: To investigate the possible predominance of certain Klebsiella pneumoniae capsular types in the pathogenesis of ankylosing spondylitis (AS).

Methods: The prevalence of IgA class antibodies against three different K. pneumoniae strains (with capsular types 21, 30 and 43) was studied in the sera of 177 patients with AS and of 100 healthy blood donors using an enzyme-linked immunosorbent assay.

Results: The median Klebsiella-specific antibody levels were always higher in patients than in controls regardless of the serotype used as antigen. When the prevalence of increased antibody levels was compared between the groups, it was highest against the strain with capsular type 30, whereas against strains 21 and 43 it was similar among patients and controls.

Conclusions: A broad range of Klebsiella serotypes may be involved in the pathogenesis of AS. Thus, it is important to take the different Klebsiella serotypes into particular account in these studies.

目的:探讨某些肺炎克雷伯菌荚膜型在强直性脊柱炎(AS)发病中的可能优势。方法:采用酶联免疫吸附法测定177例AS患者和100例健康献血者血清中3种不同肺炎克雷伯菌(荚膜型21、30和43)IgA类抗体的流行情况。结果:无论使用何种血清型抗原,患者的克雷伯氏菌特异性抗体中位数水平始终高于对照组。当比较各组之间抗体水平升高的流行率时,对荚膜类型为30的菌株的抗体水平最高,而对菌株21和43的抗体水平在患者和对照组之间相似。结论:广泛的克雷伯菌血清型可能参与了AS的发病机制。因此,在这些研究中特别考虑不同的克雷伯菌血清型是很重要的。
{"title":"IgA class serum antibodies against three different Klebsiella serotypes in ankylosing spondylitis.","authors":"O Mäki-Ikola,&nbsp;M Nissilä,&nbsp;K Lehtinen,&nbsp;K Granfors","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the possible predominance of certain Klebsiella pneumoniae capsular types in the pathogenesis of ankylosing spondylitis (AS).</p><p><strong>Methods: </strong>The prevalence of IgA class antibodies against three different K. pneumoniae strains (with capsular types 21, 30 and 43) was studied in the sera of 177 patients with AS and of 100 healthy blood donors using an enzyme-linked immunosorbent assay.</p><p><strong>Results: </strong>The median Klebsiella-specific antibody levels were always higher in patients than in controls regardless of the serotype used as antigen. When the prevalence of increased antibody levels was compared between the groups, it was highest against the strain with capsular type 30, whereas against strains 21 and 43 it was similar among patients and controls.</p><p><strong>Conclusions: </strong>A broad range of Klebsiella serotypes may be involved in the pathogenesis of AS. Thus, it is important to take the different Klebsiella serotypes into particular account in these studies.</p>","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1299-302"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term outcomes of an arthritis self-management programme. 关节炎自我管理方案的长期结果。
Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1315
J H Barlow, A P Turner, C C Wright

Objective: A previous UK evaluation of the Arthritis Self-Management Programme (ASMP) demonstrated 4 month improvements in physical and psychological well-being including increased arthritis self-efficacy and increased use of self-management behaviours such as cognitive symptom management, and reductions in pain, fatigue and anxiety. The purpose of this study was to determine whether these effects were maintained at 12 month follow-up.

Methods: Twelve month data were collected via self-administered questionnaires mailed to participants who had previously responded prior to attending the ASMP and at 4 months follow-up.

Results: The sample (n = 112) comprised 82% women with a mean age of 59.6 (S.D. 12.4) yr and a mean disease duration of 14.9 (S.D. 11.1) yr. The majority of participants had a general practitioner-recorded diagnosis of either rheumatoid arthritis (46%) or osteoarthritis (44%). Many of the changes noted at 4 months were sustained at the 12 month follow-up.

Conclusion: This first long-term evaluation of a community-based patient education intervention delivered in the UK suggests that after participation in the ASMP, persons with arthritis derive substantial and prolonged benefits in terms of perceived ability to manage arthritis, reduction in pain and improved psychological well-being.

目的:先前英国对关节炎自我管理计划(ASMP)的评估表明,4个月后,患者的身体和心理健康得到改善,包括关节炎自我效能的提高,认知症状管理等自我管理行为的使用增加,疼痛、疲劳和焦虑的减少。本研究的目的是确定这些效果是否在12个月的随访中保持。方法:12个月的数据通过邮寄给参加ASMP之前有回应的参与者的自我管理问卷和4个月的随访收集。结果:样本(n = 112)包括82%的女性,平均年龄为59.6 (S.D. 12.4)年,平均病程为14.9 (S.D. 11.1)年。大多数参与者有全科医生记录的类风湿关节炎(46%)或骨关节炎(44%)的诊断。许多在4个月时观察到的变化在12个月的随访中持续存在。结论:这项在英国进行的基于社区的患者教育干预的首次长期评估表明,参加ASMP后,关节炎患者在管理关节炎、减轻疼痛和改善心理健康方面获得了实质性和长期的益处。
{"title":"Long-term outcomes of an arthritis self-management programme.","authors":"J H Barlow,&nbsp;A P Turner,&nbsp;C C Wright","doi":"10.1093/rheumatology/37.12.1315","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1315","url":null,"abstract":"<p><strong>Objective: </strong>A previous UK evaluation of the Arthritis Self-Management Programme (ASMP) demonstrated 4 month improvements in physical and psychological well-being including increased arthritis self-efficacy and increased use of self-management behaviours such as cognitive symptom management, and reductions in pain, fatigue and anxiety. The purpose of this study was to determine whether these effects were maintained at 12 month follow-up.</p><p><strong>Methods: </strong>Twelve month data were collected via self-administered questionnaires mailed to participants who had previously responded prior to attending the ASMP and at 4 months follow-up.</p><p><strong>Results: </strong>The sample (n = 112) comprised 82% women with a mean age of 59.6 (S.D. 12.4) yr and a mean disease duration of 14.9 (S.D. 11.1) yr. The majority of participants had a general practitioner-recorded diagnosis of either rheumatoid arthritis (46%) or osteoarthritis (44%). Many of the changes noted at 4 months were sustained at the 12 month follow-up.</p><p><strong>Conclusion: </strong>This first long-term evaluation of a community-based patient education intervention delivered in the UK suggests that after participation in the ASMP, persons with arthritis derive substantial and prolonged benefits in terms of perceived ability to manage arthritis, reduction in pain and improved psychological well-being.</p>","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1315-9"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1315","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 149
Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis. 强直性脊柱炎患者肺炎克雷伯菌脂多糖抗体的研究。
Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1330
K Ahmadi, C Wilson, H Tiwana, A Binder, A Ebringer

The role of microbial lipopolysaccharides (LPS) in the aetiopathogenesis of ankylosing spondylitis (AS) is a matter of continuing debate. In this study, class-specific IgG, IgA and IgM antibodies against Klebsiella pneumoniae, Escherichia coli, Salmonella typhimurium and Salmonella enteritidis LPS were measured by enzyme-linked immunosorbent assay (ELISA) in 100 AS patients, 50 rheumatoid arthritis (RA) patients and 50 healthy control subjects. The AS patients had significantly elevated levels of IgG and IgA antibodies against K. pneumoniae LPS (P < 0.001) and IgA antibodies against E. coli LPS (P < 0.05) compared to healthy controls. There were no significant elevations of antibody levels against S. typhimurium and S. enteritidis in the three study groups. In addition, there was a correlation between IgG and IgA anti-K. pneumoniae LPS antibody levels and the acute-phase reactant C-reactive protein (P < 0.001).

微生物脂多糖(LPS)在强直性脊柱炎(AS)的发病机制中的作用是一个持续争论的问题。本研究采用酶联免疫吸附试验(ELISA)检测100例AS患者、50例类风湿性关节炎(RA)患者和50例健康对照者对肺炎克雷伯菌、大肠杆菌、鼠伤寒沙门菌和肠炎沙门菌的类特异性IgG、IgA和IgM抗体。AS患者抗肺炎克雷伯菌LPS的IgG和IgA抗体水平(P < 0.001)和抗大肠杆菌LPS的IgA抗体水平(P < 0.05)均显著高于健康对照组。在三个研究组中,鼠伤寒沙门氏菌和肠炎沙门氏菌的抗体水平没有显著升高。IgG与IgA anti-K有相关性。肺炎链球菌LPS抗体水平和急性期反应物c反应蛋白(P < 0.001)。
{"title":"Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis.","authors":"K Ahmadi,&nbsp;C Wilson,&nbsp;H Tiwana,&nbsp;A Binder,&nbsp;A Ebringer","doi":"10.1093/rheumatology/37.12.1330","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1330","url":null,"abstract":"<p><p>The role of microbial lipopolysaccharides (LPS) in the aetiopathogenesis of ankylosing spondylitis (AS) is a matter of continuing debate. In this study, class-specific IgG, IgA and IgM antibodies against Klebsiella pneumoniae, Escherichia coli, Salmonella typhimurium and Salmonella enteritidis LPS were measured by enzyme-linked immunosorbent assay (ELISA) in 100 AS patients, 50 rheumatoid arthritis (RA) patients and 50 healthy control subjects. The AS patients had significantly elevated levels of IgG and IgA antibodies against K. pneumoniae LPS (P < 0.001) and IgA antibodies against E. coli LPS (P < 0.05) compared to healthy controls. There were no significant elevations of antibody levels against S. typhimurium and S. enteritidis in the three study groups. In addition, there was a correlation between IgG and IgA anti-K. pneumoniae LPS antibody levels and the acute-phase reactant C-reactive protein (P < 0.001).</p>","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1330-3"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1330","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 34
期刊
British journal of rheumatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1